Skip to main content
. 2020 Oct 16;229:33–40. doi: 10.1016/j.jpeds.2020.10.026

Figure 3.

Figure 3

Medical management of MIS-C often varied by severity, with severity being defined differently by each center. For centers that recommended IVIG, 54% recommended a second dose for patients who were refractory to the first dose. Medications used by ≤20 of the 40 centers are not shown. LMWH, low molecular weight heparin.